XK
ABBV icon

Xact Kapitalforvaltning’s AbbVie ABBV Stock Holding History

Xact Kapitalforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$25M Buy
327,843
+1,939
+0.6% +$165K 0.53% 39
2019
Q4 		$28.9M Buy
325,904
+6,645
+2% +$552K 0.49% 39
2019
Q3 		$24.2M Buy
319,259
+21,898
+7% +$1.5M 0.46% 43
2019
Q2 		$21.6M Buy
297,361
+17,422
+6% +$1.37M 0.45% 42
2019
Q1 		$22.6M Buy
279,939
+4,158
+2% +$340K 0.51% 38
2018
Q4 		$25.4M Sell
275,781
-4,877
-2% -$429K 0.65% 26
2018
Q3 		$26.5M Sell
280,658
-25,595
-8% -$2.43M 0.56% 31
2018
Q2 		$28.4M Sell
306,253
-8,313
-3% -$812K 0.6% 29
2018
Q1 		$29.8M Buy
314,566
+11,375
+4% +$1.25M 0.67% 26
2017
Q4 		$29.3M Buy
303,191
+5,716
+2% +$539K 0.7% 26
2017
Q3 		$26.4M Buy
297,475
+4,133
+1% +$315K 0.76% 28
2017
Q2 		$21.3M Buy
293,342
+14,788
+5% +$994K 0.65% 31
2017
Q1 		$18.2M Buy
278,554
+28,796
+12% +$1.81M 0.56% 33
2016
Q4 		$15.6M Buy
249,758
+11,136
+5% +$680K 0.55% 35
2016
Q3 		$15.1M Buy
+238,622
New +$15.4M 0.53% 39

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Xact Kapitalforvaltning's ABBV Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its AbbVie (ABBV) stake by 0.59% in Q1 2020, buying an estimated $165K and bringing the position to 327,843 shares worth $25M. The position accounts for 0.53% of the portfolio, ranked #39.

Xact Kapitalforvaltning first reported a position in ABBV in Q3 2016 and has held it in 15 quarters since. The position peaked at $29.8M in Q1 2018. 2,226 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Xact Kapitalforvaltning held 327,843 shares of AbbVie worth $25M as of Q1 2020.
  • Xact Kapitalforvaltning bought 1,939 AbbVie shares in Q1 2020, an estimated $165K.
  • AbbVie made up 0.53% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #39 holding.
  • Xact Kapitalforvaltning first reported a position in AbbVie in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's AbbVie position peaked at $29.8M in Q1 2018.
  • 2,226 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.